Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.
A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers.
The GpHA and Biosimilars Council have published their objections to the Trans-Pacific Partnership trade agreement to the pages of the New York Times.
As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply.
The Israeli Health Ministry approved on Monday a decision to allow patients licensed to receive medical marijuana from a pharmacy with authorization from a medical expert, according to theJerusalem Post.
The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection.
The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.
In a move that will reshape the generic pharmaceuticals landscape, Teva announced Monday that it would be acquiring Allergan Generics for $40.5 billion.
Anthem, Inc. will acquire all outstanding shares of Cigna Corporation in a transaction valued at $54.2 billion.
The National Association of Chain Drug Stores today announced that the Exhibit Hall for the 2015 NACDS Total Store Expo, which will take place from Aug. 22 to 25 at the Colorado Convention Center in Denver, is sold out.